New Emerging Issues Brief

Refusing Cancer Medications to Avoid Delirium and Maintain Autonomy By Kimberly Petrovic, PhD MSN MA RN, Assistant Professor of Nursing, SCSU Thomas O. Blank, Ph.D., Professor Emeritus, Human Development and Family Studies, UConn    Shared decision-making within the patient-provider relationship is considered a cornerstone of the contemporary treatment of cancer here in Connecticut as well as nationally. It will be the focus of the 2017 Annual Meeting of the Connecticut Cancer Partnership. The relationship between patient and provider is critical and needs to develop and grow without diminishing the ultimate goals of cancer treatment: cure (whenever possible) and comfort (as…

The Role of Genomics in Breast Cancer

Join The Jackson Laboratory for Genomic Medicine (JAX) for three upcoming educational events on the role of genomics in breast cancer. Through a generous grant from the Connecticut Breast Health Initiative Inc., these unique events will incorporate perspectives from breast cancer survivors, clinicians, and researchers to provide insight into current and future uses of genomics in breast cancer detection, diagnosis, treatment, and ongoing management.   Beyond Genetics: genomics in breast cancer diagnosis, treatment and research Register here for the April 18, 2017  event – Early detection and diagnosis Register here for the May 2, 2017 event – Treatment and Precision…

Triple Negative Breast Cancer Research from Yale

Researchers at Yale Cancer Center have identified a new subtype of triple negative breast cancer that shows significantly improved response to chemotherapy. Patients with the newly defined subtype — BRCA-deficient triple negative breast cancer — had significantly higher survival rates with chemotherapy. The study was published on Dec. 13 in PLOS Medicine. Triple negative breast cancer (TNBC) disproportionately affects young women of all races and women of African ancestry, contributing to health disparities. In an era when personalized cancer therapy has improved survival rates, patients with TNBC remain at considerably higher risk of relapse and death than patients with other…

Public Health Genomics Knowledge Base

The CDC Public Health Genomics Knowledge Base is an online, continuously updated, searchable database of published scientific literature, CDC resources, and other materials that address the translation of genomic discoveries into improved health care and disease prevention. The Knowledge Base, cosponsored by the Division of Cancer Control and Population Sciences at the National Cancer Institute, is curated by CDC staff and is regularly updated to reflect ongoing developments in the field. This compendium of databases can be searched for genomics-related information on any specific topic. We will continue to add additional features to the knowledge base and are interested in…

The 2016 Connecticut Cancer Champion Award

Among the highlights of our very successful Annual Meeting, held on Dec. 6, 2016 was the awarding of the first Cancer Champion Award. The 2016 Connecticut Cancer Champion Award is awarded to Andrea Silber, MD for her contributions to cancer prevention and control in our state.  This is the first Connecticut Cancer Champion Award to be given annually to an outstanding Connecticut resident who contributes to cancer prevention and control in our state, and who demonstrates commitment to reducing the burden of cancer in Connecticut through work on policy, systems and environmental change.   Dr. Silber is a Medical Oncologist at Smilow Cancer…